Tag: phase-2b-dronabinol-clinical-trial

Commercial & Investment Banking Picture Gallery

RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017

January 6, 2017
Presse

CEO to Review Completed Phase 2B Dronabinol Clinical Trial for the Treatment of Obstructive Sleep Apnea…

Continue Reading